Ardent Health (ARDT) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 9, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ARDT filings

Are insiders buying or selling Ardent Health Partners, Inc. (ARDT) stock?

Neither. Ardent Health Partners, Inc. (ARDT) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ARDT recently?

None. No member of Congress disclosed a ARDT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ARDT smart-money data?

This summary uses filings available on Nov 9, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on ARDT

Lean long2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
- Robert DeMichiei, bought $98.3K, open market, filed Jun 8
- Alfred Lumsdaine, bought $88.1K, open market, filed Jun 8
Lean long · thin2 buys · $186K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
- AQR, added +$6.2M, holdings at Jun 30
Lean long · thin1 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ARDT filings

Are insiders buying or selling Ardent Health Partners, Inc. (ARDT) stock?

Neither. Ardent Health Partners, Inc. (ARDT) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ARDT recently?

None. No member of Congress disclosed a ARDT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ARDT smart-money data?

Funds

What funds are doing

1 move · 6 mo

Buys/Adds$6.2M

Buys/Adds (1)

AQ
AQR
Q2 2026 13F
$6.2M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 4, 2026

Earnings came in 29.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 4, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.31+29.17% beat

$0.24 expected

Revenue

$1.62B

SEC filing

Next report

Estimated report: Nov 11, 2026, in 2 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 4, 2026	$0.31est. $0.24	+29.17%beat	$1.62BSEC filing	+3.1%from $1.58B
Jun 30, 2026Reported Aug 4, 2026	$0.12est. $0.17	-29.41%miss	$1.62BSEC filing	-1.4%from $1.65B
Mar 31, 2026Reported May 5, 2026	$0.30est. $0.18	+66.67%beat	$1.60BSEC filing	+7.0%from $1.50B
Dec 31, 2025Reported Mar 4, 2026	$0.36est. $0.35	+4.48%beat	$6.32B · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	$0.83est. $0.42	+97.62%beat	$1.58BSEC filing	+8.8%from $1.45B
Jun 30, 2025Reported Aug 5, 2025	$0.55est. $0.32	+71.88%beat	$1.65BSEC filing	+11.9%from $1.47B
Mar 31, 2025Reported May 6, 2025	$0.19est. $0.21	-9.52%miss	$1.50BSEC filing	+4.0%from $1.44B
Dec 31, 2024Reported Feb 26, 2025	$0.81est. $0.46	+77.36%beat	$5.97B · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $15.84
High: $17.68
Low: $15.58
Prev close: $15.90
52-wk high: $17.68
52-wk low: $7.71
Mkt cap: $2.44B
P/E: 16.8x
ROE: +13.5%
Fwd P/E: 15.5x
Beta: 0.58
P/S: 0.4x
P/B: 1.7x
Profit margin: +2.3%
Op margin: +5.9%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 2.3%
P/E: 16.80
Forward P/E: 15.46
Market cap: $2.4B

Valuation

P/S0.38
P/B1.75

Quality

Operating margin5.9%
ROE13.5%
ROA4.0%

Growth

Beta0.58

Technicals

Price structure

This stock is in a strong uptrend, and looks overbought after a fast run-up.

Trend

Strong uptrend

85 / 100

RSI 14

85overbought

20D volatility

87%annualized

52-week range

$17.30

$7.71$17.68

20D support

$11.03recent floor

20D resistance

$17.68recent ceiling

Returns

5D +43.8%20D +53.1%60D +57.0%

Price vs moving averages

SMA20 +38.6%SMA50 +51.2%SMA200 +71.0%

Volume pace

1.66xvs prior 20D

Smart money at a glance

Filings to Nov 9, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ARDT filings

Are insiders buying or selling Ardent Health Partners, Inc. (ARDT) stock?

Neither. Ardent Health Partners, Inc. (ARDT) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ARDT recently?

None. No member of Congress disclosed a ARDT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ARDT smart-money data?

13F: filed up to 45 days late.

Smart money on ARDT

Lean long2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
- Robert DeMichiei, bought $98.3K, open market, filed Jun 8
- Alfred Lumsdaine, bought $88.1K, open market, filed Jun 8
Lean long · thin2 buys · $186K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
- AQR, added +$6.2M, holdings at Jun 30
Lean long · thin1 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ARDT filings

Are insiders buying or selling Ardent Health Partners, Inc. (ARDT) stock?

Neither. Ardent Health Partners, Inc. (ARDT) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ARDT recently?

None. No member of Congress disclosed a ARDT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ARDT smart-money data?

Funds

What funds are doing

1 move · 6 mo

Buys/Adds$6.2M

Buys/Adds (1)

AQ
AQR
Q2 2026 13F
$6.2M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 4, 2026

Earnings came in 29.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 4, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.31+29.17% beat

$0.24 expected

Revenue

$1.62B

SEC filing

Next report

Estimated report: Nov 11, 2026, in 2 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 4, 2026	$0.31est. $0.24	+29.17%beat	$1.62BSEC filing	+3.1%from $1.58B
Jun 30, 2026Reported Aug 4, 2026	$0.12est. $0.17	-29.41%miss	$1.62BSEC filing	-1.4%from $1.65B
Mar 31, 2026Reported May 5, 2026	$0.30est. $0.18	+66.67%beat	$1.60BSEC filing	+7.0%from $1.50B
Dec 31, 2025Reported Mar 4, 2026	$0.36est. $0.35	+4.48%beat	$6.32B · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	$0.83est. $0.42	+97.62%beat	$1.58BSEC filing	+8.8%from $1.45B
Jun 30, 2025Reported Aug 5, 2025	$0.55est. $0.32	+71.88%beat	$1.65BSEC filing	+11.9%from $1.47B
Mar 31, 2025Reported May 6, 2025	$0.19est. $0.21	-9.52%miss	$1.50BSEC filing	+4.0%from $1.44B
Dec 31, 2024Reported Feb 26, 2025	$0.81est. $0.46	+77.36%beat	$5.97B · FYSEC filing	No year-ago quarter

Open: $15.84
High: $17.68
Low: $15.58
Prev close: $15.90
52-wk high: $17.68
52-wk low: $7.71
Mkt cap: $2.44B
P/E: 16.8x
ROE: +13.5%
Fwd P/E: 15.5x
Beta: 0.58
P/S: 0.4x
P/B: 1.7x
Profit margin: +2.3%
Op margin: +5.9%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 2.3%
P/E: 16.80
Forward P/E: 15.46
Market cap: $2.4B

Valuation

P/S0.38
P/B1.75

Quality

Operating margin5.9%
ROE13.5%
ROA4.0%

Growth

Beta0.58

Technicals

Price structure

This stock is in a strong uptrend, and looks overbought after a fast run-up.

Trend

Strong uptrend

85 / 100

RSI 14

85overbought

20D volatility

87%annualized

52-week range

$17.30

$7.71$17.68

20D support

$11.03recent floor

20D resistance

$17.68recent ceiling

Returns

5D +43.8%20D +53.1%60D +57.0%

Price vs moving averages

SMA20 +38.6%SMA50 +51.2%SMA200 +71.0%

Volume pace

1.66xvs prior 20D

Ardent Health Partners, Inc.

Smart money at a glance

What do analysts expect?

Questions about ARDT filings

Smart money on ARDT

Questions about ARDT filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 29.2% above what analysts expected.

Estimated report: Nov 11, 2026, in 2 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Ardent Health Partners, Inc.

Smart money at a glance

What do analysts expect?

Questions about ARDT filings

Smart money on ARDT

Questions about ARDT filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 29.2% above what analysts expected.

Estimated report: Nov 11, 2026, in 2 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Ardent Health Partners, Inc.

Overview

Questions about ARDT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Ardent Health Partners, Inc.

Overview

Questions about ARDT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.